Company Fountain Biopharma Inc

Equities

4159

TW0004159009

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 23:00:00 11/08/2019 BST			5-day change	1st Jan Change
16.75 ^TWD	-0.30%		-1.93%	-.--%

Fountain Biopharma Inc. is a Taiwan-based company principally engaged in the research, development and sales of antibody drugs. The Company's main products include an anti-allergy single-injection antibody, FB825-Anti-CmX; a single-injection antibody, FB704A-Anti-IL6; a biosimilar drug, FB317-Omalizumab, and a biosimilar drug, FB121-Ibalizumab. The Company has not generated any revenue for the past two years.

Managers	Title	Age	Since
Hui Fang Huang CEO	Chief Executive Officer	-	-
Wen Tzu Hsiao DFI	Director of Finance/CFO	-	12/06/16
Nien Yi Chen IRC	Investor Relations Contact	-	29/02/12
Hung Chou PRN	Corporate Officer/Principal	-	-
Shu Yue Chen AUD	Comptroller/Controller/Auditor	-	17/08/16

Members of the board	Title	Age	Since
Chun Hung Chen BRD	Director/Board Member	69	05/09/17
Yung Hung Chung BRD	Director/Board Member	-	05/09/17
Hui Fang Huang CEO	Chief Executive Officer	-	-
Kuo Chen Li BRD	Director/Board Member	-	10/06/13
Mei An Liu BRD	Director/Board Member	-	05/09/17
Hsuan Ta Liu BRD	Director/Board Member	-	10/06/13
Chi Chou Liao BRD	Director/Board Member	-	10/06/13
Hong Chiun Wang BRD	Director/Board Member	58	05/09/17
Nien Yi Chen IRC	Investor Relations Contact	-	29/02/12
Wen Liang Huang BRD	Director/Board Member	-	05/09/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	302,423,000	35,164,000 ( 11.63 %)	20,649,450 ( 6.828 %)	11.63 %

Fountain Biopharma, Inc.

19/F-1 3 Yuanqu Street

115 03, Taipei

http://www.fountainmab.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
FOUNTAIN BIOPHARMA INC	-.--%	161M
MODERNA, INC.	+37.76%	53.67B
LONZA GROUP AG	+33.50%	38.86B
IQVIA HOLDINGS INC.	-8.45%	38.76B
CELLTRION, INC.	-10.77%	27.27B
ICON PUBLIC LIMITED COMPANY	+11.40%	25.91B
ALNYLAM PHARMACEUTICALS, INC.	-15.60%	20.29B
UNITED THERAPEUTICS CORPORATION	+32.92%	12.78B
MEDPACE HOLDINGS, INC.	+28.12%	12.18B
BIO-TECHNE CORPORATION	-2.61%	11.96B

Other Biotechnology & Medical Research